INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2004

Being an equol producer was linked to lower rates of prostate cancer in Japanese and Korean case-control groups.

Researchers compared the percentage of equol producers between prostate cancer patients and controls in Japan, Korea, and the United States. The percentage of equol producers among patients versus controls was 29% and 46% in Japan (P = 0.004) and 30% and 59% in Korea (P = 0.001). Among Americans, active isoflavone levels were markedly lower and the percentage of equol producers was lower (17% for patients and 14% for controls) compared to Japanese and Korean participants.

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
295 subjects in Japan (133 patients, 162 controls), 122 in Korea (61 patients, 61 controls), and 45 in the United States (24 patients, 21 controls)
What was measured
Percentage of equol producers and active isoflavone levels

THE PAPER

Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.

Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. Jpn J Clin Oncol, 2004.

PubMed 15067102 ↗DOI 10.1093/jjco/hyh015 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.